AHG — Akso Health Cashflow Statement

0.000.00%

Last trade - 00:00

TechnologySpeculativeMicro CapNeutral

Annual cashflow statement for Akso Health, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-31.6	-16.8	-13.1	-9.12	-135
Depreciation
Deferred Taxes
Non-Cash Items	18.4	10.8	11	8.41	162
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	23.2	-2.56	-1.17	2.06	3.02
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities	10.1	-8.63	-3.25	1.35	1.18
Capital Expenditures	0	-0.005	—	—	-0.154
Purchase of Fixed Assets
Other Investing Cash Flow Items	-0.001	-20	18.5	-54.7	-106
Acquisition of Business
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-0.001	-20	18.5	-54.7	-106
Financing Cash Flow Items	0.037	10	0	139	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-9.04	34.8	-27.5	132	196
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	4.2	6.8	-12.7	77	90